SOR Special Terms Sample Clauses
SOR Special Terms. Project implementation is expected to begin by the third month of the grant. SOR funds must be used to address the opioid overdose crisis by increasing access to FDA- approved medications for the treatment of opioid use disorder (MOUD), and for supporting the continuum of prevention, harm reduction, treatment, and recovery support services for opioid use disorder (OUD) and other concurrent substance use disorders. SOR funds may also support the continuum of care for stimulant misuse and use disorders, including for cocaine and methamphetamine. State Meetings: Grantee will attend monthly state technical assistance calls or assign SOR coordinator to do this on your behalf and report out to staff as needed.
SOR Special Terms a. SAMHSA requires that medications for the treatment of opioid use disorder (MOUD) is made available to those diagnosed with opioid use disorder (OUD). MOUD includes FDA- approved treatments such as methadone, buprenorphine products, including single- entity buprenorphine products, buprenorphine/naloxone tablets, films, buccal preparations, long-acting injectable buprenorphine products, and injectable extended- release naltrexone.
b. SOR grant funds must be used to provide services or practices that have a proven evidence base and are appropriate for the population(s) of focus.
c. SOR funds shall not be utilized for services which can be supported through other accessible sources of funding such as other federal discretionary and formula grant funds, ((e.g., HHS, CDC, CMS, HRSA, and SAMHSA), DOJ (OJP/BJA)), and non-federal funds, third party insurance, and sliding scale self-pay among others.
d. SOR funds for treatment and recovery support services shall only be utilized to provide services to individuals that specifically address opioid or stimulant misuse issues. If either an opioid or stimulant misuse problem (history) exists concurrently with other substance use, all substance use issues may be addressed. Individuals who have no history of or no current issues with opioids or stimulants misuse shall not receive treatment or recovery services with SOR grant funds.
e. Grantee is required to comply with all additional data collection requirements of the SOR grant project. Recipients shall fully participate in any SAMHSA-sponsored evaluation of the SOR grant program. The submission of these data in the form required by SAMHSA is a requirement of funding. Noncompliance with this requirement may result in restricted access to funding for this year or limited or no access to funding in the future grant year.
f. Grantee must implement prevention and education services including training of peers, first responders, and other key community sectors on recognition of opioid overdose and appropriate use of the opioid overdose antidote naloxone, developing evidence-based community prevention efforts such as strategic messaging on the consequences of opioid and stimulant misuse, implementing school-based prevention programs and outreach, and purchasing and distributing opioid overdose antidote reversal naloxone, based on the naloxone distribution and saturation plan, and train on its use.
g. Grantee is required to work with SAMHSA-funded SOR/Tribal Opioid Response T...